FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2767843430> ?p ?o ?g. }

• W2767843430 endingPage "175" @default.
• W2767843430 startingPage "161" @default.
• W2767843430 abstract "Over activation of glial cell derived innate immune factors induces neuro-inflammation that results in neurodegenerative disease, like working memory impairment. In this study, we have investigated the role of andrographolide, a major constituent of Andrographis paniculata plant, in reduction of reactive glial cell derived working memory impairment. Real time PCR, Western bloting, flow cytometric and immunofluorescence studies demonstrated that andrographolide inhibited lipopolysaccharide (LPS)-induced overexpression of HMGB1, TLR4, NFκB, COX-2, iNOS, and release of inflammatory mediators in primary mix glial culture, adult mice prefrontal cortex and hippocampus region. Active microglial and reactive astrocytic makers were also downregulated after andrographolide treatment. Andrographolide suppressed overexpression of microglial MIP-1α, P2X7 receptor and its downstream signaling mediators including-inflammasome NLRP3, caspase1 and mature IL-1β. Furthermore, in vivo maze studies suggested that andrographolide treatment reversed LPS-induced behavioural and working memory disturbances including regulation of expression of protein markers like PKC, p-CREB, amyloid beta, APP, p-tau, synapsin and PSD-95. Andrographolide, by lowering expression of pro apoptotic genes and enhancing the expression of anti-apoptotic gene showed its anti-apoptotic nature that in turn reduces neurodegeneration. Morphology studies using Nissl and FJB staining also showed the neuroprotective effect of andrographolide in the prefrontal cortex region. The above studies indicated that andrographolide prevented neuroinflammation-associated neurodegeneration and improved synaptic plasticity markers in cortical as well as hippocampal region which suggests that andrographolide could be a novel pharmacological countermeasure for the treatment of neuroinflammation and neurological disorders related to memory impairment." @default.
• W2767843430 created "2017-11-17" @default.
• W2767843430 creator A5030020357 @default.
• W2767843430 creator A5034888051 @default.
• W2767843430 creator A5058825253 @default.
• W2767843430 creator A5062048275 @default.
• W2767843430 date "2017-12-01" @default.
• W2767843430 modified "2023-09-27" @default.
• W2767843430 title "Andrographolide - A promising therapeutic agent, negatively regulates glial cell derived neurodegeneration of prefrontal cortex, hippocampus and working memory impairment" @default.
• W2767843430 cites W1491294744 @default.
• W2767843430 cites W1519306389 @default.
• W2767843430 cites W1634993844 @default.
• W2767843430 cites W1974700087 @default.
• W2767843430 cites W1977592558 @default.
• W2767843430 cites W1979096652 @default.
• W2767843430 cites W1983589036 @default.
• W2767843430 cites W2007856289 @default.
• W2767843430 cites W2028491403 @default.
• W2767843430 cites W2033690212 @default.
• W2767843430 cites W2034154165 @default.
• W2767843430 cites W2038438278 @default.
• W2767843430 cites W2039390013 @default.
• W2767843430 cites W2056686776 @default.
• W2767843430 cites W2057809738 @default.
• W2767843430 cites W2064064873 @default.
• W2767843430 cites W2068054859 @default.
• W2767843430 cites W2072598425 @default.
• W2767843430 cites W2083700985 @default.
• W2767843430 cites W2085662710 @default.
• W2767843430 cites W2089486556 @default.
• W2767843430 cites W2099157718 @default.
• W2767843430 cites W2103780005 @default.
• W2767843430 cites W2106083328 @default.
• W2767843430 cites W2109759840 @default.
• W2767843430 cites W2117780076 @default.
• W2767843430 cites W2124334590 @default.
• W2767843430 cites W2128916701 @default.
• W2767843430 cites W2140636567 @default.
• W2767843430 cites W2156047020 @default.
• W2767843430 cites W2338113233 @default.
• W2767843430 cites W837349641 @default.
• W2767843430 doi "https://doi.org/10.1016/j.jneuroim.2017.11.003" @default.
• W2767843430 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29146293" @default.
• W2767843430 hasPublicationYear "2017" @default.
• W2767843430 type Work @default.
• W2767843430 sameAs 2767843430 @default.
• W2767843430 citedByCount "41" @default.
• W2767843430 countsByYear W27678434302018 @default.
• W2767843430 countsByYear W27678434302019 @default.
• W2767843430 countsByYear W27678434302020 @default.
• W2767843430 countsByYear W27678434302021 @default.
• W2767843430 countsByYear W27678434302022 @default.
• W2767843430 countsByYear W27678434302023 @default.
• W2767843430 crossrefType "journal-article" @default.
• W2767843430 hasAuthorship W2767843430A5030020357 @default.
• W2767843430 hasAuthorship W2767843430A5034888051 @default.
• W2767843430 hasAuthorship W2767843430A5058825253 @default.
• W2767843430 hasAuthorship W2767843430A5062048275 @default.
• W2767843430 hasConcept C142724271 @default.
• W2767843430 hasConcept C169760540 @default.
• W2767843430 hasConcept C169900460 @default.
• W2767843430 hasConcept C185592680 @default.
• W2767843430 hasConcept C203014093 @default.
• W2767843430 hasConcept C204787440 @default.
• W2767843430 hasConcept C25498285 @default.
• W2767843430 hasConcept C2776914184 @default.
• W2767843430 hasConcept C2776925932 @default.
• W2767843430 hasConcept C2777970627 @default.
• W2767843430 hasConcept C2779134260 @default.
• W2767843430 hasConcept C2779965356 @default.
• W2767843430 hasConcept C2781161787 @default.
• W2767843430 hasConcept C2781195155 @default.
• W2767843430 hasConcept C2781357234 @default.
• W2767843430 hasConcept C529278444 @default.
• W2767843430 hasConcept C71924100 @default.
• W2767843430 hasConcept C86803240 @default.
• W2767843430 hasConcept C87753298 @default.
• W2767843430 hasConcept C98274493 @default.
• W2767843430 hasConceptScore W2767843430C142724271 @default.
• W2767843430 hasConceptScore W2767843430C169760540 @default.
• W2767843430 hasConceptScore W2767843430C169900460 @default.
• W2767843430 hasConceptScore W2767843430C185592680 @default.
• W2767843430 hasConceptScore W2767843430C203014093 @default.
• W2767843430 hasConceptScore W2767843430C204787440 @default.
• W2767843430 hasConceptScore W2767843430C25498285 @default.
• W2767843430 hasConceptScore W2767843430C2776914184 @default.
• W2767843430 hasConceptScore W2767843430C2776925932 @default.
• W2767843430 hasConceptScore W2767843430C2777970627 @default.
• W2767843430 hasConceptScore W2767843430C2779134260 @default.
• W2767843430 hasConceptScore W2767843430C2779965356 @default.
• W2767843430 hasConceptScore W2767843430C2781161787 @default.
• W2767843430 hasConceptScore W2767843430C2781195155 @default.
• W2767843430 hasConceptScore W2767843430C2781357234 @default.
• W2767843430 hasConceptScore W2767843430C529278444 @default.
• W2767843430 hasConceptScore W2767843430C71924100 @default.
• W2767843430 hasConceptScore W2767843430C86803240 @default.
• W2767843430 hasConceptScore W2767843430C87753298 @default.
• W2767843430 hasConceptScore W2767843430C98274493 @default.

• next